These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Uricosuric effect of benzbromaronum on a model of pyrazine amide-induced hyperuricemia]. Kropp R. Med Klin; 1970 Aug 01; 65(32):1448-50. PubMed ID: 5523876 [No Abstract] [Full Text] [Related]
6. [Uric acid-lowering effect of a combination of benzbromarone and allopurinol--studies under standardized dietary conditions]. Löffler W, Gröbner W, Zöllner N. Arzneimittelforschung; 1983 Aug 01; 33(12):1687-91. PubMed ID: 6686776 [Abstract] [Full Text] [Related]
17. [On the decrease of uric acid level in the plasma with benzbromarone]. Zöllner N, Stern G, Gröbner W, Dofel W. Klin Wochenschr; 1968 Dec 15; 46(24):1318-9. PubMed ID: 5714791 [No Abstract] [Full Text] [Related]
18. Benzbromarone therapy in hyperuricaemia. Scott WA. J Int Med Res; 1981 Dec 15; 9(1):82-7. PubMed ID: 7009259 [Abstract] [Full Text] [Related]
19. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia]. Kotzaurek R, Hueber EF. Wien Med Wochenschr; 1968 Nov 23; 118(47):1014-8. PubMed ID: 5704263 [No Abstract] [Full Text] [Related]
20. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks]. Brzozowska-Jurkowska AM. Reumatologia; 1980 Nov 23; 18(3):287-92. PubMed ID: 6999575 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]